Wider Circle works with health plans nationally to deliver unique hyper-local care programs that connect neighbors for better health. The company’s trusted delivery network has been proven to drive resilience, improve member experience and engagement and reduce hospitalizations. Today, Wider Circle offers its innovative programs across 12 states.

Reducing billions of dollars in prescription drugs costs for employees and large, self-insured employers

• Raised $12M at increasing valuations from blue chip investors including Johnson & Johnson• Exceeded Seed and Series A milestones by delivering project 20% ahead of schedule and 35% under budget• Drove a complex, Class III device from concept to clinical trials on 60% of competitor burn• Managed OUS clinical trial yielding successful results and 1.3x valuation increase in 4 months• Built a strong management team consisting of individuals with successful commercial track records and over 20 years average experience• Grew a lean, driven organization of 32 FTEs with R&D, operations, finance, clinical, and marketing expertise• Recruited advisors from leading institutions (i.e. CCF, BIDMC, etc.) and medical society boards• Created a vertically integrated and certified 12,000 sq ft medical device R&D and manufacturing facility• Secured 3 US patents, multiple international patents, and managed FTO risk in an extremely crowded space

Updated the entire BioDesign curriculum, which became the framework for the BioDesign textbook

• Developed a dynamic pricing strategy for a Phase III biologic with multiple cardiovascular indications • Analyzed commercial opportunity for a competitive indication and delivered strategic roadmap to executives• Forecasted sales and optimal launch spend (sales force/marketing) for lead program that improved asset value

• Core team leader for CRM’s #3 priority project – managed $6M and 50 people to develop and launch a Class III medical device• Forecasted the lifecycle of a $250M instrument asset for the corporate strategic plan• Managed EHR integration strategies with Cleveland Clinic resulting in industry’s first device-to-EHR transfer• Developed communication plans for executive presentations to Wall Street and internal leadership• Awarded Star of Excellence, company’s highest honor, for defining and launching top business unit initiative

• Defined a top 4 company strategy, Connectivity, that leveraged product portfolio to create market synergies• Managed $250K release budget to showcase Connectivity at largest industry tradeshow• Global Marketing Award Finalist for developing cross-portfolio strategies

• Structured cash flow models and company valuations for M&A, equity, and debt pitches• Researched in-licensing strategies and synthesized comparative biotech company indicators

• Evaluated commercial potential and intellectual property value of engineering research projects • Networked with venture capitalists to market emerging business opportunities

• Led Milcom’s first assessment of biotechnology investment opportunities• Created venture capital investment presentations for portfolio companies